PLRX 10-Q: SEC filing

Pliant Therapeutics

Filed with the SEC on Nov 12, 2026 · accession 0001746473-26-000125

PLRX filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. Pliant Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, cash position, and operating results. The stock moved -4.8% by the first close after the filing.

Summary of the filing

Pliant Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, cash position, and operating results. No major corporate events such as executive changes, acquisitions, or regulatory actions were announced in this filing.

For details, click here →How to read a 10-Q →

Key details

FilerPliant Therapeutics, Inc.

How PLRX stock reacted

Close before

$0.78

Nov 11, 2026

First close after

-4.84%

$0.74

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PLRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PLRX?

Click here

Frequently asked questions

What did PLRX file with the SEC on Nov 12, 2026?

PLRX filed a 10-Q (SEC filing). Pliant Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, cash position, and operating results. No major corporate events such as executive changes, acquisitions, or regulatory actions were announced in this filing.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did PLRX stock react to this filing?

PLRX closed at $0.78 before the filing and $0.74 on Nov 12, 2026 (-4.84%).

Other PLRX SEC filings

Get alerts when PLRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

PLRX overview PLRX analysis PLRX news Latest SEC filings